Lorcaserin Extended-Release Tablets and Pegaptanib Intraocular
Determining the interaction of Lorcaserin Extended-Release Tablets and Pegaptanib Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: pegaptanib ophthalmic
Brand name: Macugen
Synonyms: Pegaptanib ophthalmic injection, Pegaptanib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Pegaptanib ophthalmic injection
- Lorcaserin Extended-Release Tablets-Pegaptanib Sodium
- Lorcaserin Extended-Release Tablets-Pegaspargase
- Lorcaserin Extended-Release Tablets-Pegaspargase Intramuscular, Intravenous
- Lorcaserin Extended-Release Tablets-Pegasys
- Lorcaserin Extended-Release Tablets-Pegasys ProClick
- Pegaptanib Intraocular-Lorcaserin Hydrochloride
- Pegaptanib Intraocular-Lorcaserin Tablets
- Pegaptanib Intraocular-Lorcet
- Pegaptanib Intraocular-Lorcet Plus
- Pegaptanib Intraocular-Lorcet Tablets
- Pegaptanib Intraocular-Lorlatinib